GTHP: Guided Therapeutics, Inc. Stock

by  •  • Comments Off on GTHP: Guided Therapeutics, Inc. Stock

SIC 3845 – Electromedical and Electrotherapeutic Apparatus

Valuation
Market Cap ($M) 7.64
Enterprise Value ($M) 12.26
Book Value ($M) -4.89
Book Value / Share -0.06
Price / Book -1.56
NCAV ($M) -5.07
NCAV / Share -0.07
Price / NCAV -1.51

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.62
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.09
Current Ratio 0.19

Balance Sheet (mrq) ($M)
Current Assets 1.20
Assets 1.38
Liabilities 6.27
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.01
Operating Income -2.11
Net Income -2.42
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -1.12
Cash from Investing 0.00
Cash from Financing 0.92

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Auctus Fund Management Llc 9.90 8.93

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTI
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)

Similar Companies
GEGP – Gold Entertainment Group, Inc. GIPL – Global Innovative Platforms Inc.
GPFT – Grapefruit USA, Inc. HDII – Hypertension Diagnostics, Inc.
HLTT – Healthtech Solutions Inc.


Financial data and stock pages provided by
Fintel.io